Wealthspire Advisors (Maryland)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-20,040	Closed	-$306K	–	2371
2018 Q2	$306K	Buy	20,040 +33	+0.2%	+$588	0.03%	358
2018 Q1	$450K	Buy	20,007 +19,940	+29,761%	+$552K	0.04%	265
2017 Q4	$2K	Buy	67 +25	+60%	+$799	﹤0.01%	2079
2017 Q3	$2K	Buy	42 +36	+600%	+$1.17K	﹤0.01%	1952
2017 Q2	$0	Sell	6 -42	-88%	-$1.25K	﹤0.01%	2180
2017 Q1	$2K	Buy	48 +43	+860%	+$1.52K	﹤0.01%	1669
2016 Q4	$0	Sell	5 -4	-44%	-$106	﹤0.01%	1741
2016 Q3	$0	Buy	9 +4	+80%	+$136	﹤0.01%	1722
2016 Q2	$0	Buy	+5	New	+$167	﹤0.01%	1680
2016 Q1	–	Sell	-46	Closed	-$2K	–	1731
2015 Q4	$2K	Buy	+46	New	+$1.62K	﹤0.01%	1508